Published :
Tables : 44
Figures : 50
Category : Chemicals & Advanced Materials
No. of Pages : 220
Report Code : CAM1017
Chromatography Resin Market is poised to value over USD 3.74 billion by 2027 end at a CAGR of over 8% during the forecast period 2020 to 2027. Growth in drug discovery processes to find a cure for Zika, Ebola, and other such deadly viruses are anticipated to boost the demand of the market over the forecast period. In addition, strict guidelines issued by food regulatory authorities around the world are anticipated to propel the market for chromatography resins over the forecast period. Moreover, the growing pharmaceutical industry in emerging economies like China and India is expected to have a positive impact on the industry. Natural resin is estimated to be the largest type segment and is expected to gain significant share due to its low cost and easy to use qualities. Synthetic resin is expected to grow at a significant CAGR, owing to high productivity which enables its applications in continuous production. An increasing number of manufacturing and distribution units in the developing market is also expected to boost demand over the next eight years. High demand for affinity chromatography resin due to its rising applications in pharmaceutical companies is expected to fuel growth in the near future. In addition, wide usage by the biotechnology sector in monoclonal antibodies for therapeutic purposes is anticipated to further propel market growth. Ion exchange resin is used in the separation of many complex mixtures, which is anticipated to contribute to the demand. Factors such as high cost compared to other separation techniques due to high-priced raw materials and transportation are expected to pose a challenge for the market for chromatography resin. Additionally, the need for high-skilled professionals to operate these processes is expected to restrict market development in the near future. The North American market held the largest market share and is expected to maintain its dominance in the coming years owing to the surging pharmaceutical industry in the region. The US is the major contributor in the region owing to advanced chromatography techniques and ongoing research and development facilities for the development of biologics and drugs. Europe accounted for the second-largest market share owing to increasing healthcare expenditure. The Asia-Pacific market is expected to grow at the highest CAGR owing to the rising demand for the product in food and beverages and healthcare end-use industry. India and China are the major contributors due to rising government funding in pharmaceutical research activities and the easy availability of cheap labor. Major players included in the Chromatography Resin Market: • Bio-Rad Laboratories, Inc. (US) • Tosoh Corporation (Japan) • Pall Corporation (US) • Thermo Fisher Scientific Inc. (US) • Mitsubishi Chemical Corporation (Japan) • Avantor Performance Materials, Inc. (US) • GE Healthcare (US) • Merck KGaA (Germany) • W. R. Grace & Co. (US) • Purolite Corporation (US) • Repligen Corporation (US) • Agilent Technologies • Kaneka Corporation • Novasep • Sepragen Corporation • Sterogene Bioseparations Inc. • Finex Oy • Chemra GmbH • Sunresin New Materials Co. Ltd. • Biotoolomics Limited • Cube Biotech • Jsr Life Sciences • Ningbo Zhengguang Resin Co., Ltd. • Concise Separations • Genscript Biotech Corporation • Eichrom Technologies Inc. Chromatography Resin Market Segmentation: By Type • Natural Polymer o Agarose o Dextran o Others • Synthetic Polymer o Silica o Polystyrene o Others • Inorganic Media By Technique • Ion Exchange Chromatography o Cation Exchange Chromatography o Anion Exchange Chromatography • Affinity Chromatography o Bio-Specific Ligand-Based Affinity Chromatography o Pseudo Bio-Specific Ligand-Based Affinity Chromatography • Hydrophobic Interaction Chromatography • Size Exclusion Chromatography • Multimodal Chromatography • Others By Application • Pharmaceutical & Biotechnology o Production o Academics & Research • Food & Beverage • Water & Environmental Analysis • Others By Region • North America • Europe • Asia Pacific • Latin America • Rest of the World Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways • Growth prospects • SWOT analysis • Key trends • Key data points affecting market growth Objectives of the Study: • To provide an exhaustive analysis on the global chromatography resin market by type, by technique, by application, and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Growth in drug discovery processes to find a cure for Zika, Ebola, and other such deadly viruses are anticipated to boost the demand of the market over the forecast period. In addition, strict guidelines issued by food regulatory authorities around the world are anticipated to propel the market for chromatography resins over the forecast period. Moreover, the growing pharmaceutical industry in emerging economies like China and India is expected to have a positive impact on the industry.
Natural resin is estimated to be the largest type segment and is expected to gain significant share due to its low cost and easy to use qualities. Synthetic resin is expected to grow at a significant CAGR, owing to high productivity which enables its applications in continuous production. An increasing number of manufacturing and distribution units in the developing market is also expected to boost demand over the next eight years.
High demand for affinity chromatography resin due to its rising applications in pharmaceutical companies is expected to fuel growth in the near future. In addition, wide usage by the biotechnology sector in monoclonal antibodies for therapeutic purposes is anticipated to further propel market growth. Ion exchange resin is used in the separation of many complex mixtures, which is anticipated to contribute to the demand.
Factors such as high cost compared to other separation techniques due to high-priced raw materials and transportation are expected to pose a challenge for the market for chromatography resin. Additionally, the need for high-skilled professionals to operate these processes is expected to restrict market development in the near future.
The North American market held the largest market share and is expected to maintain its dominance in the coming years owing to the surging pharmaceutical industry in the region. The US is the major contributor in the region owing to advanced chromatography techniques and ongoing research and development facilities for the development of biologics and drugs.
Europe accounted for the second-largest market share owing to increasing healthcare expenditure. The Asia-Pacific market is expected to grow at the highest CAGR owing to the rising demand for the product in food and beverages and healthcare end-use industry. India and China are the major contributors due to rising government funding in pharmaceutical research activities and the easy availability of cheap labor.
Major players included in the Chromatography Resin Market: • Bio-Rad Laboratories, Inc. (US) • Tosoh Corporation (Japan) • Pall Corporation (US) • Thermo Fisher Scientific Inc. (US) • Mitsubishi Chemical Corporation (Japan) • Avantor Performance Materials, Inc. (US) • GE Healthcare (US) • Merck KGaA (Germany) • W. R. Grace & Co. (US) • Purolite Corporation (US) • Repligen Corporation (US) • Agilent Technologies • Kaneka Corporation • Novasep • Sepragen Corporation • Sterogene Bioseparations Inc. • Finex Oy • Chemra GmbH • Sunresin New Materials Co. Ltd. • Biotoolomics Limited • Cube Biotech • Jsr Life Sciences • Ningbo Zhengguang Resin Co., Ltd. • Concise Separations • Genscript Biotech Corporation • Eichrom Technologies Inc.
Chromatography Resin Market Segmentation:
By Type • Natural Polymer o Agarose o Dextran o Others • Synthetic Polymer o Silica o Polystyrene o Others • Inorganic Media
By Technique • Ion Exchange Chromatography o Cation Exchange Chromatography o Anion Exchange Chromatography • Affinity Chromatography o Bio-Specific Ligand-Based Affinity Chromatography o Pseudo Bio-Specific Ligand-Based Affinity Chromatography • Hydrophobic Interaction Chromatography • Size Exclusion Chromatography • Multimodal Chromatography • Others
By Application • Pharmaceutical & Biotechnology o Production o Academics & Research • Food & Beverage • Water & Environmental Analysis • Others
By Region • North America • Europe • Asia Pacific • Latin America • Rest of the World
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Takeaways • Growth prospects • SWOT analysis • Key trends • Key data points affecting market growth
Objectives of the Study: • To provide an exhaustive analysis on the global chromatography resin market by type, by technique, by application, and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Chromatography Resin Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Chromatography Resin Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Chromatography Resin Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Chromatography Resin Market,By Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Natural Polymer 7.1.1. Agarose 7.1.2. Dextran 7.1.3. Others 7.2. Synthetic Polymer 7.2.1. Silica 7.2.2. Polystyrene 7.2.3. Others 7.3. Inorganic Media 8. Global Chromatography Resin Market,By Technique Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Ion Exchange Chromatography 8.1.1. Cation Exchange Chromatography 8.1.2. Anion Exchange Chromatography 8.2. Affinity Chromatography 8.2.1. Bio-Specific Ligand-Based Affinity Chromatography 8.2.2. Pseudo Bio-Specific Ligand-Based Affinity Chromatography 8.3. Hydrophobic Interaction Chromatography 8.4. Size Exclusion Chromatography 8.5. Multimodal Chromatography 8.6. Others 9. Global Chromatography Resin Market,By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Pharmaceutical & Biotechnology 9.1.1. Production 9.1.2. Academics & Research 9.2. Food & Beverage 9.3. Water & Environmental Analysis 9.4. Others 10. North America Chromatography Resin Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Chromatography Resin Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Chromatography Resin Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Chromatography Resin Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts) 16.1. Bio-Rad Laboratories, Inc. (US) 16.1.1. Company Overview 16.1.2. Type Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Tosoh Corporation (Japan) 16.2.1. Company Overview 16.2.2. Type Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Pall Corporation (US) 16.3.1. Company Overview 16.3.2. Type Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Thermo Fisher Scientific Inc. (US) 16.4.1. Company Overview 16.4.2. Type Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Mitsubishi Chemical Corporation (Japan) 16.5.1. Company Overview 16.5.2. Type Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Avantor Performance Materials, Inc. (US) 16.6.1. Company Overview 16.6.2. Type Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. GE Healthcare (US) 16.7.1. Company Overview 16.7.2. Type Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Merck KGaA (Germany) 16.8.1. Company Overview 16.8.2. Type Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. W. R. Grace & Co. (US) 16.9.1. Company Overview 16.9.2. Type Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Purolite Corporation (US) 16.10.1. Company Overview 16.10.2. Type Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Repligen Corporation (US) 16.11.1. Company Overview 16.11.2. Type Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Agilent Technologies 16.12.1. Company Overview 16.12.2. Type Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Kaneka Corporation 16.13.1. Company Overview 16.13.2. Type Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Novasep 16.14.1. Company Overview 16.14.2. Type Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Sepragen Corporation 16.15.1. Company Overview 16.15.2. Type Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Sterogene Bioseparations Inc. 16.16.1. Company Overview 16.16.2. Type Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Finex Oy 16.17.1. Company Overview 16.17.2. Type Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Chemra GmbH 16.18.1. Company Overview 16.18.2. Type Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19.Sunresin New Materials Co. Ltd. 16.19.1. Company Overview 16.19.2. Type Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20.Biotoolomics Limited 16.20.1. Company Overview 16.20.2. Type Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview 16.21.Cube Biotech 16.21.1. Company Overview 16.21.2. Type Portfolio 16.21.3. SWOT Analysis 16.21.4. Financial Overview 16.21.5. Strategic Overview 16.22.Jsr Life Sciences 16.22.1. Company Overview 16.22.2. Type Portfolio 16.22.3. SWOT Analysis 16.22.4. Financial Overview 16.22.5. Strategic Overview 16.23.Ningbo Zhengguang Resin Co., Ltd 16.23.1. Company Overview 16.23.2. Type Portfolio 16.23.3. SWOT Analysis 16.23.4. Financial Overview 16.23.5. Strategic Overview 16.24.Concise Separations 16.24.1. Company Overview 16.24.2. Type Portfolio 16.24.3. SWOT Analysis 16.24.4. Financial Overview 16.24.5. Strategic Overview 16.25.Genscript Biotech Corporation 16.25.1. Company Overview 16.25.2. Type Portfolio 16.25.3. SWOT Analysis 16.25.4. Financial Overview 16.25.5. Strategic Overview 16.26.Eichrom Technologies Inc. 16.26.1. Company Overview 16.26.2. Type Portfolio 16.26.3. SWOT Analysis 16.26.4. Financial Overview 16.26.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Chromatography Resin Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Chromatography Resin Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Chromatography Resin Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Chromatography Resin Market,By Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Natural Polymer 7.1.1. Agarose 7.1.2. Dextran 7.1.3. Others 7.2. Synthetic Polymer 7.2.1. Silica 7.2.2. Polystyrene 7.2.3. Others 7.3. Inorganic Media
8. Global Chromatography Resin Market,By Technique Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Ion Exchange Chromatography 8.1.1. Cation Exchange Chromatography 8.1.2. Anion Exchange Chromatography 8.2. Affinity Chromatography 8.2.1. Bio-Specific Ligand-Based Affinity Chromatography 8.2.2. Pseudo Bio-Specific Ligand-Based Affinity Chromatography 8.3. Hydrophobic Interaction Chromatography 8.4. Size Exclusion Chromatography 8.5. Multimodal Chromatography 8.6. Others
9. Global Chromatography Resin Market,By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Pharmaceutical & Biotechnology 9.1.1. Production 9.1.2. Academics & Research 9.2. Food & Beverage 9.3. Water & Environmental Analysis 9.4. Others
10. North America Chromatography Resin Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Latin America Chromatography Resin Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2020-2027
12. Europe Chromatography Resin Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027
13. Asia Pacific Chromatography Resin Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts) 16.1. Bio-Rad Laboratories, Inc. (US) 16.1.1. Company Overview 16.1.2. Type Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Tosoh Corporation (Japan) 16.2.1. Company Overview 16.2.2. Type Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Pall Corporation (US) 16.3.1. Company Overview 16.3.2. Type Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Thermo Fisher Scientific Inc. (US) 16.4.1. Company Overview 16.4.2. Type Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Mitsubishi Chemical Corporation (Japan) 16.5.1. Company Overview 16.5.2. Type Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Avantor Performance Materials, Inc. (US) 16.6.1. Company Overview 16.6.2. Type Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. GE Healthcare (US) 16.7.1. Company Overview 16.7.2. Type Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Merck KGaA (Germany) 16.8.1. Company Overview 16.8.2. Type Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. W. R. Grace & Co. (US) 16.9.1. Company Overview 16.9.2. Type Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Purolite Corporation (US) 16.10.1. Company Overview 16.10.2. Type Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Repligen Corporation (US) 16.11.1. Company Overview 16.11.2. Type Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Agilent Technologies 16.12.1. Company Overview 16.12.2. Type Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Kaneka Corporation 16.13.1. Company Overview 16.13.2. Type Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Novasep 16.14.1. Company Overview 16.14.2. Type Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Sepragen Corporation 16.15.1. Company Overview 16.15.2. Type Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Sterogene Bioseparations Inc. 16.16.1. Company Overview 16.16.2. Type Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Finex Oy 16.17.1. Company Overview 16.17.2. Type Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Chemra GmbH 16.18.1. Company Overview 16.18.2. Type Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19.Sunresin New Materials Co. Ltd. 16.19.1. Company Overview 16.19.2. Type Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20.Biotoolomics Limited 16.20.1. Company Overview 16.20.2. Type Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview 16.21.Cube Biotech 16.21.1. Company Overview 16.21.2. Type Portfolio 16.21.3. SWOT Analysis 16.21.4. Financial Overview 16.21.5. Strategic Overview 16.22.Jsr Life Sciences 16.22.1. Company Overview 16.22.2. Type Portfolio 16.22.3. SWOT Analysis 16.22.4. Financial Overview 16.22.5. Strategic Overview 16.23.Ningbo Zhengguang Resin Co., Ltd 16.23.1. Company Overview 16.23.2. Type Portfolio 16.23.3. SWOT Analysis 16.23.4. Financial Overview 16.23.5. Strategic Overview 16.24.Concise Separations 16.24.1. Company Overview 16.24.2. Type Portfolio 16.24.3. SWOT Analysis 16.24.4. Financial Overview 16.24.5. Strategic Overview 16.25.Genscript Biotech Corporation 16.25.1. Company Overview 16.25.2. Type Portfolio 16.25.3. SWOT Analysis 16.25.4. Financial Overview 16.25.5. Strategic Overview 16.26.Eichrom Technologies Inc. 16.26.1. Company Overview 16.26.2. Type Portfolio 16.26.3. SWOT Analysis 16.26.4. Financial Overview 16.26.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics